D-w Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.

Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.

Journal: Leukemia

Published: April 12, 2017

Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.

Cobll1 is linked to drug resistance and blastic transformation in chronic myeloid leukemia.

Journal: Leukemia

Published: November 07, 2016

Aminophylline Effect on Renal Ischemia-Reperfusion Injury in Mice.

Aminophylline Effect on Renal Ischemia-Reperfusion Injury in Mice.

Journal: Transplantation proceedings

Published: June 28, 2016

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale.

Journal: Leukemia

Published: March 22, 2016

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Journal: Leukemia

Published: February 29, 2016

Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia.

Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia.

Journal: Bone marrow transplantation

Published: January 05, 2016

Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials.

Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials.

Journal: Leukemia

Published: December 22, 2015

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 29, 2015

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial.

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial.

Journal: Leukemia

Published: November 02, 2015

Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation.

Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation.

Journal: Bone marrow transplantation

Published: May 12, 2015

BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase.

BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase.

Journal: Leukemia

Published: March 18, 2015

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL.

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL.

Journal: Bone marrow transplantation

Published: August 27, 2014

Showing 1-12 of 24

Last Updated: 09/26/2026